ArticleDeutsches Arzteblatt international2009
Fibromyalgia syndrome: classification, diagnosis, and treatment.
Article in Deutsches Arzteblatt international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 82 citations in OpenAlex.
- Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.The Cochrane database of systematic reviews · 2018Pooled it
- Massage therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials.PloS one · 2014Pooled it
- Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials.Rheumatology international · 2013Pooled it
- The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.CNS drugs · 2012Pooled it
- 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.Pain research & managementGuideline
- Effects of a one week multidisciplinary inpatient self-management programme for patients with fibromyalgia: a randomised controlled trial.BMC musculoskeletal disorders · 2012Trial
- Does maladaptive microvascular flow redistribution cause tissue hypoxia in fibromyalgia?Pain reports · 2026Article
- Article
- Non-Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches.Brain and behavior · 2025Article
- The Association of Pain Medication Usage and Quantitative Sensory Testing Outcomes in Fibromyalgia Patients: A Secondary Data Analysis.NeuroSci · 2025Article
- [Effects of a multimodal inpatient treatment for patients with fibromyalgia syndrome at the Rhineland-Palatinate Acute Rheumatology Center].Zeitschrift fur Rheumatologie · 2025Article
- Identification of texture MRI brain abnormalities on Fibromyalgia syndrome using interpretable machine learning models.Scientific reports · 2024Article
- 'If it's a medical issue I would have covered it by now': learning about fibromyalgia through the hidden curriculum: a qualitative study.BMC medical education · 2017Article
- Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy--a prospective controlled study.Clinical interventions in aging · 2015Article
- A patient and physician survey of fibromyalgia across Latin America and Europe.BMC musculoskeletal disorders · 2013Article
- [Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups].Zeitschrift fur Rheumatologie · 2013Article
- In-Patient Treatment of Fibromyalgia: A Controlled Nonrandomized Comparison of Conventional Medicine versus Integrative Medicine including Fasting Therapy.Evidence-based complementary and alternative medicine : eCAM · 2013Article
- Additive Complex Ayurvedic Treatment in Patients with Fibromyalgia Syndrome Compared to Conventional Standard Care Alone: A Nonrandomized Controlled Clinical Pilot Study (KAFA Trial).Evidence-based complementary and alternative medicine : eCAM · 2013Article
- Unique immunologic patterns in fibromyalgia.BMC clinical pathology · 2012Article
- [Fibromyalgia syndrome guideline: Interim assessment].Schmerz (Berlin, Germany) · 2012Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on byMeager result.2009
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis S3 guideline takes positions on currently contentious issues in the classification and treatment of fibromyalgia syndrome (FMS).
methodsA panel of experts from 10 specialist societies and patients belonging to 2 patient self-help organizations reviewed a total of approximately 8000 publications. Recommendations were developed according to the suggested procedure for S3 guidelines and were then reviewed and approved by the boards of the participating specialist societies. The steering committee ensured that the literature review and the recommendations were kept up to date.
resultsBecause this disorder is defined by its symptoms and signs, rather than by any consistently identifiable bodily lesion, the term "fibromyalgia syndrome" is a more appropriate designation for it than "fibromyalgia." FMS is defined by the criteria of the American College of Rheumatology and is classified as a functional somatic syndrome. FMS is diagnosed from the typical constellation of symptoms and by the exclusion of inflammatory and metabolic diseases that could cause the same symptoms. A stepwise treatment approach in which the patient and the physician decide jointly on the treatment options is recommended. The most strongly recommended forms of treatment are aerobic exercise, amitriptyline, cognitive behavioral therapy, and spa therapy.
conclusionsThe guideline recommendations are intended to promote more effective treatment of this disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.